Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Peter Staple
AddedMar 31, 2024
UpdatedMay 31, 2026
Peter Staple

Peter Staple

Board Member, Kyto Technology & Life Science

CrunchbaseLinkedIn

Peter Staple's Career

Kyto Technology & Life Science
Kyto Technology & Life Science

Los Altos Hills, CA, US

Board Member· Board
Assertio Holdings
Assertio Holdings

Newark, CA, US

Board Member· Board
Corsair Pharma
Corsair Pharma

Sunnyvale, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Peter Staple's Career

Kyto Technology & Life Science
Kyto Technology & Life Science
311999Los Altos Hills, CA, US
Board Member· Board

Leadership at Kyto Technology & Life Science

Georges BenarrochGeorges BenarrochCo-Founder
Jon SaxeJon SaxeBoard Member
Paul RussoPaul RussoBoard Member
Assertio Holdings
Assertio Holdings
Public$1B422020Newark, CA, US
Board Member· Board

Leadership at Assertio Holdings

Bill McKeeBill McKeeBoard Member
Dan PeisertDan PeisertBoard Member
Joshua ScheinJoshua ScheinFounder
JAMES LEE TYREEJAMES LEE TYREEBoard Member

Similar to Assertio Holdings

Auxilius PharmaAuxilius PharmaHudson, MA, USPharmaceuticalsest. 2018Auxilius PharmaHudson, MA, US · est. 2018

Auxilius Pharma: Innovating cost-effective solutions to meet unmet healthcare needs.

Seed · $2.3M8
AccuitisAccuitisAlpharetta, GA, USPharmaceuticalsest. 2011AccuitisAlpharetta, GA, US · est. 2011

Accuitis, a Georgia-based pharmaceutical company, specializes in developing treatments for niche and underserved diseases.

Pre-Seed · $3.8M2
Eton PharmaceuticalsEton PharmaceuticalsDeer Park, IL, USPharmaceuticalsest. 2017Eton PharmaceuticalsDeer Park, IL, US · est. 2017

Eton Pharmaceuticals: A US-based specialty pharma company, innovating in injectables, oral liquids, and ophthalmics.

Public · $38.1M28
Harmony BiosciencesHarmony BiosciencesPlymouth Meeting, PA, USPharmaceuticalsest. 2017Harmony BiosciencesPlymouth Meeting, PA, US · est. 2017

Harmony Biosciences: Innovating therapies for rare neurological disorders in the U.S.

Public · $1.2B200
Corsair Pharma
Corsair Pharma
Series B$23M7Sunnyvale, CA, US
Board Member· Board

Leadership at Corsair Pharma

George MahaffeyGeorge MahaffeyCEO

Similar to Corsair Pharma

CSR Pharma GroupCSR Pharma GroupBridgewater Township, NJ, USPharmaceuticalsCSR Pharma GroupBridgewater Township, NJ, US

CSR Pharma: Marketing transformative healthcare products for patients with unmet medical needs.

Angel · $150k6
Concours PharmaceuticalsConcours PharmaceuticalsTrenton, NJ, USPharmaceuticalsest. 2018Concours PharmaceuticalsTrenton, NJ, US · est. 2018

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

Seed · $2.7M30
Corridor PharmaceuticalsCorridor PharmaceuticalsTowson, MD, USDrugs, Pharmaceuticalsest. 2007Corridor PharmaceuticalsTowson, MD, US · est. 2007

Corridor Pharmaceuticals: A biopharmaceutical firm innovating therapeutic drugs for critical care diseases across the US.

Public · $27.6M6
CortriaCortriaBoston, MA, USMedicines, Pharmaceuticalsest. 2005CortriaBoston, MA, US · est. 2005

Cortria Corp: A US-based pharmaceutical company specializing in cardiovascular disease treatments.

Public · $1.8M1

Peter Staple's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Peter Staple

Peter HagenPeter HagenBoard Member · Apex VenturesSpencer C. FleischerSpencer C. FleischerBoard Member · FFL PartnersAndrew BogleAndrew BogleBoard Member · AlumnifireRobert YorgensenRobert YorgensenBoard Member · STR HoldingsLen PerhamLen PerhamBoard Member · PeaxyPeter McKellarPeter McKellarBoard Member · 3i